Molbank (May 2022)

Probing Adamantane Arylhydroxamic Acids against <i>Trypanosoma brucei</i> and <i>Trypanosoma cruzi</i>

  • Angeliki Sofia Foscolos,
  • Andrew Tsotinis,
  • Martin C. Taylor,
  • John M. Kelly,
  • Ioannis P. Papanastasiou

DOI
https://doi.org/10.3390/M1363
Journal volume & issue
Vol. 2022, no. 2
p. M1363

Abstract

Read online

In this work, we present the synthesis and the anti-trypanosomal activity of the 2-(4-(adamant-1-yl)phenyl)-N-hydroxyarylamides, 1a,b and the 2-(4-(adamant-1-yl)phenoxy)-N-hydroxyacetamide, 1c. The 4-(adamant-1-yl)phenyl- and 4-(adamant-1-yl)phenoxy- moieties, which are endowed with promising drug-like properties, are functionalized at the side chain termini as hydroxamic acids. The phenoxy acetohydroxamic derivative, 1c, shows the most interesting profile in terms of activity and toxicity against trypanosomes and merits further investigation.

Keywords